BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34191154)

  • 21. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
    Wong C; Lin M; Chicco A; Benson R
    Acta Radiol; 2011 Oct; 52(8):899-904. PubMed ID: 21873505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.
    Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI
    Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of focal thyroid lesions incidentally detected in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography images.
    Yaylali O; Kirac FS; Yuksel D; Marangoz E
    Indian J Cancer; 2014; 51(3):236-240. PubMed ID: 25494112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies].
    Achury C; Estorch M; Domènech A; Camacho V; Flotats A; Jaller R; Geraldo L; Deportós J; Montes A; Carrió I
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):205-9. PubMed ID: 24560597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid stimulating hormone levels.
    Pruthi A; Choudhury PS; Gupta M; Taywade S
    Indian J Nucl Med; 2015; 30(1):16-20. PubMed ID: 25589800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?
    Boeckmann J; Bartel T; Siegel E; Bodenner D; Stack BC
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):906-12. PubMed ID: 22307576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Significance of
    Makis W; Ciarallo A
    Mol Imaging Radionucl Ther; 2017 Jun; 26(2):76-82. PubMed ID: 28613200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
    Basu S; Houseni M; Alavi A
    Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
    Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
    Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management.
    Adas M; Adas G; Koc B; Ozulker F
    Minerva Endocrinol; 2015 Sep; 40(3):169-75. PubMed ID: 26205646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Clinical Significance of Incidental Focal
    Gökden Y; Özülker F; Özülker T
    Mol Imaging Radionucl Ther; 2022 Jun; 31(2):96-103. PubMed ID: 35770960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography.
    Shie P; Cardarelli R; Sprawls K; Fulda KG; Taur A
    Nucl Med Commun; 2009 Sep; 30(9):742-8. PubMed ID: 19561553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of 18F-FDG PET/CT thyroid incidentalomas andthe prevalence of malignancy: a prospective study.
    Şencan Eren M; Özdoğan Ö; Gedik A; Ceylan M; Güray Durak M; Seçil M; Koçdor MA; Çömlekçi A; Durak H
    Turk J Med Sci; 2016 Apr; 46(3):840-7. PubMed ID: 27513265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of Incidental Focal Versus Diffuse Thyroid Uptake on FDG-PET Imaging.
    Chen W; Li G; Parsons M; Zhuang H; Alavi A
    PET Clin; 2007 Jul; 2(3):321-9. PubMed ID: 27158013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidental Focal (18)F-FDG Uptake in the Prostate: Clinical Significance and Differential Diagnostic Criteria.
    Cho SK; Choi JY; Yoo J; Cheon M; Lee JY; Hyun SH; Lee EJ; Lee KH; Kim BT
    Nucl Med Mol Imaging; 2011 Sep; 45(3):192-6. PubMed ID: 24900003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Frequency of malignancy in thyroid incidentalomas detected by whole body 18F-FDG PET/CT].
    Ladrón de Guevara H D; Munizaga M C; García S N; Letelier B C; Wash F A
    Rev Med Chil; 2020 Jan; 148(1):10-16. PubMed ID: 32730431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology.
    Kang BJ; O JH; Baik JH; Jung SL; Park YH; Chung SK
    Ann Nucl Med; 2009 Oct; 23(8):729-37. PubMed ID: 19768518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.
    Bertagna F; Treglia G; Piccardo A; Giubbini R
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3866-75. PubMed ID: 22904176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.